The effect of PDE5 Inhibitors on the male reproductive tract

The therapeutic range of cyclic nucleotide phosphodiesterase 5 inhibitors (PDE5) inhibitors is getting wider in the last years. This review study focuses on the potential employment of PDE5 inhibitors as an adjunct tool for the therapeutic management of male infertility. The literature tends to sugg...

Full description

Saved in:
Bibliographic Details
Main Authors: Sofikitis, Nikolaos (Author) , Kaltsas, Aris (Author) , Dimitriadis, Fotios (Author) , Rassweiler, Jens (Author) , Grivas, Nikolaos (Author) , Zachariou, Athanasios (Author) , Kaponis, Apostolos (Author) , Tsounapi, Panagiota (Author) , Paterakis, Napoleon (Author) , Karagiannis, Andreas (Author) , Skouros, Sotirios (Author) , Giannakis, Ioannis (Author) , Champilomatis, Ioannis (Author) , Paschopoulos, Minas (Author) , Daphnis, Diamantis (Author) , Giakoumakis, Ioannis (Author) , R. Gabales, Melinda (Author) , Chua, Jo Ben M. (Author) , Lantin, Pedro L. Lantin (Author) , Mamoulakis, Charalampos (Author) , Takenaka, Atsushi (Author)
Format: Article (Journal)
Language:English
Published: 2021
In: Current pharmaceutical design
Year: 2021, Volume: 27, Issue: 23, Pages: 2697-2713
ISSN:1873-4286
DOI:10.2174/1381612826666200226121510
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2174/1381612826666200226121510
Verlag, lizenzpflichtig, Volltext: https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=DynamicDOIArticle&SrcApp=WOS&KeyAID=10.2174%2F1381612826666200226121510&DestApp=DOI&SrcAppSID=EUW1ED0AFCiGao12SJQmnrwNuZrNs&SrcJTitle=CURRENT+PHARMACEUTICAL+DESIGN&DestDOIRegistrantName=Bentham+Science
Get full text
Author Notes:Nikolaos Sofikitis, Aris Kaltsas, Fotios Dimitriadis, Jens Rassweiler, Nikolaos Grivas, Athanasios Zachariou, Apostolos Kaponis, Panagiota Tsounapi, Napoleon Paterakis, Andreas Karagiannis, Sotirios Skouros, Ioannis Giannakis, Ioannis Champilomatis, Minas Paschopoulos, Diamantis Daphnis, Ioannis Giakoumakis, Melinda R. Gabales, Jo Ben M. Chua, Pedro L. Lantin Lantin, Charalampos Mamoulakis and Atsushi Takenaka

MARC

LEADER 00000caa a2200000 c 4500
001 1801657939
003 DE-627
005 20230426073510.0
007 cr uuu---uuuuu
008 220512s2021 xx |||||o 00| ||eng c
024 7 |a 10.2174/1381612826666200226121510  |2 doi 
035 |a (DE-627)1801657939 
035 |a (DE-599)KXP1801657939 
035 |a (OCoLC)1341459928 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Sofikitis, Nikolaos  |e VerfasserIn  |0 (DE-588)1257361120  |0 (DE-627)1801660719  |4 aut 
245 1 4 |a The effect of PDE5 Inhibitors on the male reproductive tract  |c Nikolaos Sofikitis, Aris Kaltsas, Fotios Dimitriadis, Jens Rassweiler, Nikolaos Grivas, Athanasios Zachariou, Apostolos Kaponis, Panagiota Tsounapi, Napoleon Paterakis, Andreas Karagiannis, Sotirios Skouros, Ioannis Giannakis, Ioannis Champilomatis, Minas Paschopoulos, Diamantis Daphnis, Ioannis Giakoumakis, Melinda R. Gabales, Jo Ben M. Chua, Pedro L. Lantin Lantin, Charalampos Mamoulakis and Atsushi Takenaka 
264 1 |c 2021 
300 |a 17 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a First online: 26 February, 2020 
500 |a Gesehen am 12.05.2022 
520 |a The therapeutic range of cyclic nucleotide phosphodiesterase 5 inhibitors (PDE5) inhibitors is getting wider in the last years. This review study focuses on the potential employment of PDE5 inhibitors as an adjunct tool for the therapeutic management of male infertility. The literature tends to suggest a beneficial effect of PDE5 inhibitors on Leydig and Sertoli cells secretory function. It also appears that PDE5 inhibitors play a role in the regulation of the contractility of the testicular tunica albuginea and the epididymis. Moreover, scientific data suggest that PDE5 inhibitors enhance the prostatic secretory function leading to an improvement in sperm motility. Other studies additionally demonstrate the role of PDE5 inhibitors in the regulation of the sperm capacitation process. Placebo-controlled, randomized, blind studies are necessary to unambiguously incorporate PDE5 inhibitors as an adjunct tool for the pharmaceutical treatment of semen disorders and male infertility. 
650 4 |a acrosome reaction 
650 4 |a atrial-natriuretic-peptide 
650 4 |a cell-specific expression 
650 4 |a chronic sildenafil treatment 
650 4 |a cyclic-nucleotide phosphodiesterase 
650 4 |a epididymis 
650 4 |a follicle-stimulating-hormone 
650 4 |a functional-activity 
650 4 |a human sperm motility 
650 4 |a in-vitro 
650 4 |a PDE5 inhibitors 
650 4 |a phosphodiesterase 
650 4 |a prostate 
650 4 |a rat vas-deferens 
650 4 |a seminal vesicles 
650 4 |a Spermatozoa 
650 4 |a testis 
700 1 |a Kaltsas, Aris  |e VerfasserIn  |4 aut 
700 1 |a Dimitriadis, Fotios  |e VerfasserIn  |4 aut 
700 1 |a Rassweiler, Jens  |d 1955-  |e VerfasserIn  |0 (DE-588)1067480307  |0 (DE-627)818791225  |0 (DE-576)426692713  |4 aut 
700 1 |a Grivas, Nikolaos  |e VerfasserIn  |4 aut 
700 1 |a Zachariou, Athanasios  |e VerfasserIn  |4 aut 
700 1 |a Kaponis, Apostolos  |e VerfasserIn  |4 aut 
700 1 |a Tsounapi, Panagiota  |e VerfasserIn  |4 aut 
700 1 |a Paterakis, Napoleon  |e VerfasserIn  |4 aut 
700 1 |a Karagiannis, Andreas  |e VerfasserIn  |4 aut 
700 1 |a Skouros, Sotirios  |e VerfasserIn  |4 aut 
700 1 |a Giannakis, Ioannis  |e VerfasserIn  |4 aut 
700 1 |a Champilomatis, Ioannis  |e VerfasserIn  |4 aut 
700 1 |a Paschopoulos, Minas  |e VerfasserIn  |4 aut 
700 1 |a Daphnis, Diamantis  |e VerfasserIn  |4 aut 
700 1 |a Giakoumakis, Ioannis  |e VerfasserIn  |4 aut 
700 1 |a R. Gabales, Melinda  |e VerfasserIn  |4 aut 
700 1 |a Chua, Jo Ben M.  |e VerfasserIn  |4 aut 
700 1 |a Lantin, Pedro L. Lantin  |e VerfasserIn  |4 aut 
700 1 |a Mamoulakis, Charalampos  |e VerfasserIn  |4 aut 
700 1 |a Takenaka, Atsushi  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Current pharmaceutical design  |d Hilversum : Bentham Science Publ., 2000  |g 27(2021), 23, Seite 2697-2713  |h Online-Ressource  |w (DE-627)325051666  |w (DE-600)2034245-7  |w (DE-576)273880217  |x 1873-4286  |7 nnas  |a The effect of PDE5 Inhibitors on the male reproductive tract 
773 1 8 |g volume:27  |g year:2021  |g number:23  |g pages:2697-2713  |g extent:17  |a The effect of PDE5 Inhibitors on the male reproductive tract 
856 4 0 |u https://doi.org/10.2174/1381612826666200226121510  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=DynamicDOIArticle&SrcApp=WOS&KeyAID=10.2174%2F1381612826666200226121510&DestApp=DOI&SrcAppSID=EUW1ED0AFCiGao12SJQmnrwNuZrNs&SrcJTitle=CURRENT+PHARMACEUTICAL+DESIGN&DestDOIRegistrantName=Bentham+Science  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220512 
993 |a Article 
994 |a 2021 
998 |g 1067480307  |a Rassweiler, Jens  |m 1067480307:Rassweiler, Jens  |d 60000  |e 60000PR1067480307  |k 0/60000/  |p 4 
999 |a KXP-PPN1801657939  |e 4133214099 
BIB |a Y 
SER |a journal 
JSO |a {"note":["First online: 26 February, 2020","Gesehen am 12.05.2022"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1801657939","language":["eng"],"title":[{"title_sort":"effect of PDE5 Inhibitors on the male reproductive tract","title":"The effect of PDE5 Inhibitors on the male reproductive tract"}],"person":[{"display":"Sofikitis, Nikolaos","roleDisplay":"VerfasserIn","role":"aut","family":"Sofikitis","given":"Nikolaos"},{"family":"Kaltsas","given":"Aris","roleDisplay":"VerfasserIn","display":"Kaltsas, Aris","role":"aut"},{"given":"Fotios","family":"Dimitriadis","role":"aut","roleDisplay":"VerfasserIn","display":"Dimitriadis, Fotios"},{"role":"aut","display":"Rassweiler, Jens","roleDisplay":"VerfasserIn","given":"Jens","family":"Rassweiler"},{"given":"Nikolaos","family":"Grivas","role":"aut","roleDisplay":"VerfasserIn","display":"Grivas, Nikolaos"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Zachariou, Athanasios","given":"Athanasios","family":"Zachariou"},{"display":"Kaponis, Apostolos","roleDisplay":"VerfasserIn","role":"aut","family":"Kaponis","given":"Apostolos"},{"roleDisplay":"VerfasserIn","display":"Tsounapi, Panagiota","role":"aut","family":"Tsounapi","given":"Panagiota"},{"given":"Napoleon","family":"Paterakis","role":"aut","display":"Paterakis, Napoleon","roleDisplay":"VerfasserIn"},{"family":"Karagiannis","given":"Andreas","roleDisplay":"VerfasserIn","display":"Karagiannis, Andreas","role":"aut"},{"role":"aut","display":"Skouros, Sotirios","roleDisplay":"VerfasserIn","given":"Sotirios","family":"Skouros"},{"display":"Giannakis, Ioannis","roleDisplay":"VerfasserIn","role":"aut","family":"Giannakis","given":"Ioannis"},{"display":"Champilomatis, Ioannis","roleDisplay":"VerfasserIn","role":"aut","family":"Champilomatis","given":"Ioannis"},{"given":"Minas","family":"Paschopoulos","role":"aut","display":"Paschopoulos, Minas","roleDisplay":"VerfasserIn"},{"given":"Diamantis","family":"Daphnis","role":"aut","roleDisplay":"VerfasserIn","display":"Daphnis, Diamantis"},{"given":"Ioannis","family":"Giakoumakis","role":"aut","display":"Giakoumakis, Ioannis","roleDisplay":"VerfasserIn"},{"given":"Melinda","family":"R. Gabales","role":"aut","display":"R. Gabales, Melinda","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Chua, Jo Ben M.","role":"aut","family":"Chua","given":"Jo Ben M."},{"roleDisplay":"VerfasserIn","display":"Lantin, Pedro L. Lantin","role":"aut","family":"Lantin","given":"Pedro L. Lantin"},{"family":"Mamoulakis","given":"Charalampos","display":"Mamoulakis, Charalampos","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Takenaka","given":"Atsushi","display":"Takenaka, Atsushi","roleDisplay":"VerfasserIn","role":"aut"}],"physDesc":[{"extent":"17 S."}],"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 15.04.24"],"disp":"The effect of PDE5 Inhibitors on the male reproductive tractCurrent pharmaceutical design","recId":"325051666","language":["eng"],"pubHistory":["Nachgewiesen 6.2000 -"],"part":{"text":"27(2021), 23, Seite 2697-2713","volume":"27","extent":"17","year":"2021","issue":"23","pages":"2697-2713"},"title":[{"title_sort":"Current pharmaceutical design","title":"Current pharmaceutical design","subtitle":"dispatches from the front line of drug design"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2000","publisher":"Bentham Science Publ.","dateIssuedDisp":"2000-","publisherPlace":"Hilversum"}],"id":{"issn":["1873-4286"],"zdb":["2034245-7"],"eki":["325051666"]}}],"origin":[{"dateIssuedDisp":"2021","dateIssuedKey":"2021"}],"id":{"eki":["1801657939"],"doi":["10.2174/1381612826666200226121510"]},"name":{"displayForm":["Nikolaos Sofikitis, Aris Kaltsas, Fotios Dimitriadis, Jens Rassweiler, Nikolaos Grivas, Athanasios Zachariou, Apostolos Kaponis, Panagiota Tsounapi, Napoleon Paterakis, Andreas Karagiannis, Sotirios Skouros, Ioannis Giannakis, Ioannis Champilomatis, Minas Paschopoulos, Diamantis Daphnis, Ioannis Giakoumakis, Melinda R. Gabales, Jo Ben M. Chua, Pedro L. Lantin Lantin, Charalampos Mamoulakis and Atsushi Takenaka"]}} 
SRT |a SOFIKITISNEFFECTOFPD2021